The Las Vegas-based startup calls its technology VORS AMD, for vascular occlusion removal system with aspiration, mechanical and drug delivery. The approach combines nitinol baskets for mechanical thrombectomy with aspiration, clot-busting drugs and blood filtration for reinfusion.
“This is a seminal approach — a seminal design,” Retriever Medical co-founder, President and CEO Ben Bobo said in an interview with Medical Design & Outsourcing. “… There’s nobody quite doing it the way we’re doing it. And I think this design will prove itself to probably be the most effective on the market.”
Retriever Medical’s devices in development include the ClotHound ACE Blue and Gold mechanical thrombectomy catheters for deep vein thrombosis (ACE Blue) and pulmonary embolism (ACE Gold).
These catheters each have two spherical baskets for physically grabbing, breaking up and removing clots — and they could someday elute clot-busters and other drugs.
Retriever Medical is also developing aspiration catheters to work with the ClotHounds. The DogTail catheter is a 16-French aspiration catheter for use with ClotHound ACE Blue, while the large-bore DogLeg (24-French) and DogCurve (20-French) aspiration catheters are designed to work with ClotHound ACE Gold.
On top of that, Retriever Medical designed the BloodHound BOSS (blood saver system) to collect, filter and reinfuse blood removed from a patient during aspiration.
